Description: Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Home Page: www.wanbury.com
BSEL Tech Park, B-Wing
Navi Mumbai,
400703
India
Phone:
91 22 6794 2222
Officers
| Name | Title |
|---|---|
| Mr. Mohan Kumar Rayana | Whole Time Director |
| Mr. Krishnamoorthy Chandran | Vice Chairman |
| Mr. Vinod R. Verma | Chief Financial Officer |
| Mr. Jitendra Jayantilal Gandhi | Compliance Officer & Company Secretary |
| Dr. Shireesh Bhalchandra Ambhaikar | President of Operations - API Business |
| Mr. Nanasaheb Gunjal | Senior Vice President of QA,QC & RA |
| Mr. Pradeep Patni | CEO of India Formulation Business |
| Mr. Prakash Venkataraman B.E., MBA | Head of API Business |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 17.4211 |
| Price-to-Book MRQ: | 23.5159 |
| Price-to-Sales TTM: | 1.6269 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1491 |